172 related articles for article (PubMed ID: 6970159)
1. A new method of testing pancreatin therapy in vivo by the use of a peroral chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid.
Fric P; Malis F; Kasafírek E; Slabý J
Hepatogastroenterology; 1980 Jun; 27(3):220-3. PubMed ID: 6970159
[TBL] [Abstract][Full Text] [Related]
2. [Determination of the effect of pancreatin in vivo. A peroral test using the chymotrypsin substrate, (4-/acetyl-L-tyrosyl) aminobenzoic acid].
Fric P; Malis F; Kasafírek E; Slabý J
Cas Lek Cesk; 1979 Jul; 118(28):881-4. PubMed ID: 315817
[No Abstract] [Full Text] [Related]
3. [Determination of the external secretory function of the pancreas with a peroral test using the chymotrypsin substrate 4-(N-acetyl-L-tyrosyl) aminobenzoic acid. A methodological study].
Malis F; Fric P; Kasafírek E; Slabý J; Zvárová J
Cas Lek Cesk; 1981 Aug; 120(34):1014-9. PubMed ID: 6974596
[No Abstract] [Full Text] [Related]
4. Functional examination of the pancreatic secretion with 4-(n-acetyl-l-tyrosyl)aminobenzoic acid.
Malis F; Fric P; Kasafírek E; Slabý J
Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):233-7. PubMed ID: 307323
[TBL] [Abstract][Full Text] [Related]
5. [The PABA test].
Müller G; Biering A; Graubaum K; Jeschkeit H; Neubert K; Kleine R; Klapperstück M
Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):219-31. PubMed ID: 6334604
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of the peroral test with the chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid in patients with kidney diseases].
Suranová M; Malis F; Horácková M; Vrzánová M; Zelenková J; Osten J
Vnitr Lek; 1983 Sep; 29(9):890-4. PubMed ID: 6605613
[No Abstract] [Full Text] [Related]
7. [Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)].
Thienhaus R; Niederau C
Z Gastroenterol; 1979 Mar; 17(3):187-94. PubMed ID: 311979
[TBL] [Abstract][Full Text] [Related]
8. [Test with the chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)-aminobenzoic acid for the detection of the external secretory function of the pancreas. Serum levels of 4-aminobenzoic acid].
Malis F; Fric P; Slabý J; Kasafírek E; Josífko M
Cas Lek Cesk; 1982 Nov; 121(46):1425-8. PubMed ID: 6983906
[No Abstract] [Full Text] [Related]
9. [Serum paraaminobenzoic acid following the use of N-benzoyl-L-tyrosyl-paraaminobenzoic acid in the diagnosis of pancreatic insufficiency].
Wolf C; Ehrig C; Brunner H
Schweiz Med Wochenschr; 1981 Mar; 111(10):343-7. PubMed ID: 6971491
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the estimation of exocrine pancreatic function using p-(N-acetyl-L-tyrosyl)- and p-(N-benzoyl-L-tyrosyl)aminobenzoic acid.
Malis F; Fric P; Kasafírek E; Slaby J
Hepatogastroenterology; 1983 Jun; 30(3):99-101. PubMed ID: 6604011
[TBL] [Abstract][Full Text] [Related]
11. An oral test of pancreatic chymotrypsin activity using N-acetyl-L-tyrosyl-p-amino-benzoic acid in rats.
Malis F; Fric EK; Korbová L
J Clin Chem Clin Biochem; 1976 Oct; 14(10):499-500. PubMed ID: 1086887
[TBL] [Abstract][Full Text] [Related]
12. Urinary PABA recovery after oral N-benzoyl-L-tyrosyl-PABA administration combined with various exocrine pancreatic stimulants.
Cavallini G; Piubello W; Brocco G; Barba E; Baratta S; Dobrilla G; Parolin P; Bonoldi C; Scuro LA
Hepatogastroenterology; 1980 Jun; 27(3):224-6. PubMed ID: 6970160
[TBL] [Abstract][Full Text] [Related]
13. [The PABA-peptide test: a method in diagnosis of exocrine pancreatic insufficiency (author's transl)].
Schneiber E; Burgislaus E
Med Klin; 1979 Jun; 74(25):1000-3. PubMed ID: 314038
[TBL] [Abstract][Full Text] [Related]
14. [Oral administration of a chymotrypsin-labile synthetic peptide, a new test for exocrine pancreatic function, and its diagnostic value in pancreatic diseases (author's transl)].
Takayama T; Hayakawa T; Noda A; Aoki I; Horiguchi Y; Yamazaki Y; Ito K; Naruse S; Kondo T; Iinuma Y
Nihon Naika Gakkai Zasshi; 1980 Apr; 69(4):447-53. PubMed ID: 6967099
[No Abstract] [Full Text] [Related]
15. Exocrine pancreatic function test by a synthetic peptide.
Harada H; Mishima K; Shundo T; Yamamoto N; Sasaki T; Hinofuji T; Hayashi T; Uchida Y; Kimura I
Am J Gastroenterol; 1979 Jan; 71(1):45-52. PubMed ID: 312010
[TBL] [Abstract][Full Text] [Related]
16. Proof of chymotrypsin activity by a peroral test using a synthetic peptide with a C-terminal P-aminobenzoic acid residue.
Malis F; Fric P; Kasafírek E; Korbová L; Kohout J
Acta Univ Carol Med Monogr; 1977; (79 Pt 3):145-8. PubMed ID: 307905
[TBL] [Abstract][Full Text] [Related]
17. [Determination of the exocrine function of the pancreas using 4-(N-acetyl-L-tyrosyl) and 4-(N-benzoyl-L-tyrosyl) aminobenzoic acid. A comparative study].
Malis F; Fric P; Kasafírek E; Slabý J
Cas Lek Cesk; 1983 Jan; 122(1):14-7. PubMed ID: 6600653
[No Abstract] [Full Text] [Related]
18. [The study of exocrine pancreas function by means of orally administered N-benzoyl-L-tyrosyl-praaminobenzoic acid (BT-PABA-test). Evaluation after 5 years clinical experience].
Lang C; Gyr K; Borer P; Kayasseh L; Stalder GA
Schweiz Med Wochenschr; 1980 Apr; 110(14):522-8. PubMed ID: 6966425
[TBL] [Abstract][Full Text] [Related]
19. [PFD (pancreatic function diagnostant) test (exocrine pancreatic function test with oral loading of BTPABA)].
Kinugasa K; Hosoda S
Nihon Rinsho; 1979 Jun; Suppl():2447-8. PubMed ID: 315006
[No Abstract] [Full Text] [Related]
20. [Evaluation by the PABA test of the effects of cimetidine combined with pancreatic extracts in severe pancreatic insufficiency].
Delchier JC; Soulé JC; Pariente EA; Bader JP
Gastroenterol Clin Biol; 1983; 7(6-7):636-8. PubMed ID: 6603384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
